Short Interest in Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Increases By 60.1%

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 590,600 shares, a growth of 60.1% from the August 31st total of 369,000 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 5,906.0 days.

Recordati Industria Chimica e Farmaceutica Price Performance

RCDTF remained flat at $52.25 during midday trading on Friday. The company has a current ratio of 1.36, a quick ratio of 0.95 and a debt-to-equity ratio of 0.73. The company’s fifty day moving average is $52.13 and its 200 day moving average is $51.79. Recordati Industria Chimica e Farmaceutica has a 1 year low of $52.25 and a 1 year high of $52.25.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $0.70 earnings per share (EPS) for the quarter. Recordati Industria Chimica e Farmaceutica had a net margin of 17.41% and a return on equity of 30.78%. The firm had revenue of $622.00 million during the quarter.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.